Humanized CD7 CAR-T cells

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHumanized CD7 CAR-T cells

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionAnti-CD7

TargetsT-cell antigen CD7

Therapy Area/IndicationsLymphoma, T-Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesThe First Affiliated Hospital Of Soochow University

China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital Of Soochow University

Inactive CompaniesN/A

Active IndicationsLymphoma, T-Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A